There is a strong HTA and Payers presence at the World EPA Congress , making up 12% of attendees and allowing these stakeholders to play a pivotal role in determining whether new healthcare innovations succeed in the market.
Co-Chair, JCA Subgroup & Senior Advisor
Zorginstituut Nederland
Inspector General
French Ministry of Health
Head of Directorate General 1 (Drugs, Medical Devices,Biotechnology)
Federal Ministry of Health, Germany
Associate Director, AI Methods and Safety
NICE
Director
NICE Advice
Deputy Chief of the HTA Unit
Swiss Federal Office of Public Health
Director
Health Technology Assessment Department
Co-Chair
HTA Member State Coordination Group, HTA CG AGENAS